MustGrow News Releases

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

SASKATOON, Saskatchewan, July 11, 2019 – MustGrow Biologics Corp. (MGRO-CSE) (“MustGrow” or the "Company"), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry, is pleased to announce that a biopesticide R&D program is underway with the National Research Council Canada (“NRC”).

The NRC and MustGrow are conducting a series of efficacy assessments of MustGrow’s patented natural biopesticide as a natural pre-plant, pre-pot soil treatment for soil-borne pests and diseases that affect cannabis production. MustGrow intends to seek Health Canada approval of its natural biopesticide for eventual use by Canada’s licensed cannabis producers. The R&D program is currently targeting a number of soil-borne pests and diseases that have been particularly problematic for many of Canada’s licensed cannabis producers, including but not limited to:

  • Botrytis (gray mold, bud rot), a serious and common disease often brought into facilities via contaminated soil.
  • Fusarium and Rhizoctonia (root rot), known to destroy entire cannabis rooms and can lay dormant in both soil and waterlines for years before becoming active and detrimental.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

SASKATOON, Saskatchewan, July 10, 2019 – MustGrow Biologics Corp. (MGRO-CSE) (“MustGrow” or the "Company"), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers, is pleased to announce its common shares will commence trading today on the Canadian Securities Exchange under the ticker symbol "MGRO".

Full details are set out in the Company's final prospectus, dated June 20, 2019.  A copy of the final prospectus can be found under the Company's profile on SEDAR at www.sedar.com.

NOTE: THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

SASKATOON, Saskatchewan, July 8, 2019 – MustGrow Biologics Corp. (MGRO-CSE) (the "Company", “MustGrow”), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers, is pleased to announce it has received approval from the Canadian Securities Exchange ("CSE") for the listing of its common shares. The common shares will commence trading on the CSE under the ticker symbol "MGRO" at market open on Wednesday, July 10, 2019.

Full details about the Company are set out in the Company's final prospectus, dated June 20, 2019. A copy of the final prospectus can be found under the Company's profile on SEDAR at www.sedar.com.